IT News Online - Zentek Announces the Launch of Subsidiary for Aptamer-Based Platform Technology
Zentek Announces the Launch of Subsidiary for Aptamer-Based Platform Technology
Source: itnewsonline.com
📰 Platform Technology News
Page 17 - Platform Technology News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Platform Technology. Real-time updates on events, politics, business and more.
69th IEDM on December 9-13
The theme for the 69th IEDM taking place on December 9-13 at the San Francisco Union Square hotel is: “Devices for a Smart World Built Upon 60 Years of
Source: electronicsweekly.com
Sinoveda Brings "The Science of Healing" to Life
/PRNewswire/ -- There are many products on the market that contain precise synthetic ingredients. Countless others are filled with approximate doses of natural...
Hong Kong Nuzhat Tam Zaman Yunk Tam Platform Technology Natural Health Solutions Sinoveda Pharmaceutical Platform Technology
Source: prnewswire.com
Schroders UK Platform Awards 2023: Full list of winners revealed!
Here they are…the winners of the Schroders UK Platform Awards 2023.
Ruby Hinchcliffe Dunstan Thomas Momodou Musa Touray Mellon Pershing Investment Research Winterflood Business Services
Source: professionaladviser.com
ABL Bio Taps into Synaffix ADC Technology to Accelerate Development of Bispecific ADC Products
/PRNewswire/ -- Synaffix B.V., a Lonza company (SIX: LONN) focused on commercializing its clinical-stage platform technology for the development of...
Noord Holland Innovent Biologics Hoon Lee Microtubule Syntansine Microtubule Synstatin Lepu Biopharma
Source: prnewswire.com
Schroders UK Platform Awards 2023: Final set of shortlists revealed!
Here they are. Professional Adviser is proud to reveal all the shortlists for the 2023 Schroders UK Platform Awards…
United States Dunstan Thomas Platform Technology Fidelity Adviser Solutions Innovation In Workplace Solutions Workplace Solutions
Source: professionaladviser.com
Vaccinex Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Phase 1/2a SIGNAL-AD Study of Pepinemab in Alzheimer’s Disease Achieves Full Accrual Expect to Complete 12-months treatment in June, 2024 Promising Interim Results for KEYNOTE-B84 Phase 2 Trial... -Today at 08:11 am- MarketScreener
United States Albertd Friedberg Vaccinex Rochester John Mullaly Maurice Zauderer Exchange Commission
Source: marketscreener.com
Vaccinex Reports Second Quarter 2023 Financial Results and Provides Corporate Update - Vaccinex (NASDAQ:VCNX)
Phase 1/2a SIGNAL-AD Study of Pepinemab in Alzheimer's Disease Achieves Full Accrual Expect to Complete 12-months treatment in June, 2024 Promising Interim Results for KEYNOTE-B84 Phase 2 Trial in Head and Neck Cancer
United States Vaccinex Rochester Albertd Friedberg John Mullaly Maurice Zauderer Alzheimer Association
Source: benzinga.com
HeartBeam Appoints Deborah Castillo as Vice President of Regulatory Affairs
Experienced Biomedical Engineer Brings 12+ Years’ Experience in Regulatory Affairs and Quality Assurance for Medical Devices and Diagnostics with FDA and in the Private Sector ...
United States Branislav Vajdic Heartbeam Aimigo Deborah Castillo Johns Hopkins University Regulatory Affairs
Source: marketscreener.com
Sinoveda's EffectiCal Is the Perfect Calcium Supplement for Women in Their Prime
/PRNewswire/ -- Calcium supplementation is an ideal nutritional tool for post-menopausal nutritional support. For instance, John Hopkins University recommends...
Yunk Tam Nuzhat Tam Zaman John Hopkins University Platform Technology Calcium Supplementation Should Start Long Before Hopkins University
Source: prnewswire.com